China's biopharmaceuticals are expected to have a market revenue of 425 billion yuan in 2021, accounting for 24.57% of the Chinese pharmaceutical market. The compound annual growth rate of bio pharmaceutical revenue in China's pharmaceutical market from 2016 to 2021 was 18.3%, which was higher than the growth rate of China's overall pharmaceutical market revenue. It is expected that the revenue of the biopharmaceutical market will continue to grow at a relatively high rate. It is expected that the growth rate of the market revenue will be 17.6% from 2021 to 2015, and the market revenue will reach 812 billion yuan in 2025.
Market segment income scale of China's pharmaceutical industry from 2016 to 2025
Source: Frost Sullivan, organized by China Economic Industry Research Institute
The growth rate of R&D expenditure of new drugs in China also exceeds the global growth rate. According to Frost Sullivan, China's R&D expenditure will reach US $24.7 billion in 2020, and the CAGR will be 20.0% from 2016 to 2020. Frost Sullivan predicted that China's R&D expenditure is still expected to achieve a steady growth trend, with the total R&D expenditure CAGR of 15.0% from 2020 to 2025 and expected to reach 49.6 billion US dollars by 2025.
Scale and growth of China's pharmaceutical R&D expenditure in 2016-2025
Source: Frost Sullivan, organized by China Economic Industry Research Institute
Huajing Industrial Research Institute has conducted in-depth analysis on the development status quo of China's pharmaceutical industry, upstream and downstream industrial chains, competition pattern and key enterprises, so as to minimize the investment risk and operating costs of enterprises and improve their competitiveness; And use a variety of data analysis techniques to predict the development trend of the industry, so that enterprises can seize the market opportunities in time; For more details, please pay attention to the 2022-2027 China Pharmaceutical Industry Market Operation Status and Future Development Forecast Report published by Huajing Industrial Research Institute.